[Doping-related problems in clinical practice].
The complexity of the new antidoping regulations of the International Olympic Committee (IOC), the International Federations (IF) and the National Olympic Committees (NOC) rises a lot of problems in handling the prescriptions of medication in athletes in the daily practice. In addition, several countries have passed antidoping laws which makes the prescription and the delivery of doping agens illegal. This may have severe consequences for the prescribing doctors. It is therefore the goal of the article to inform the practitioning doctors about the new antidoping regulations and their impact on prescribing or delivering potential doping agens to athletes. It will focus on the new dopinglists, the different doping control systems, the problems with the pharmacological treatment of certain diseases as asthma and the necessary reports which have to be sent to the NOC's or the IF's after prescribing certain medications or methods.
Villiger
B
B
Medizinisches Zentrum Bad Ragaz. beat.villiger@resortragaz.ch
Monnat
A
A
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000428:Alcohol Drinking; D045930:Anabolic Agents / Q000494:pharmacology; D019587:Dietary Supplements; D004300:Doping in Sports / Q000331:legislation & jurisprudence / Q000517:prevention & control*; D011307:Drug Prescriptions / Q000592:standards*; D005194:Family Practice / Q000331:legislation & jurisprudence / Q000592:standards*; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D007883:Legislation, Medical; D008385:Marijuana Smoking; D017410:Practice Guidelines as Topic; D013557:Switzerland
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D045930:Anabolic Agents; D005938:Glucocorticoids